<DOC>
	<DOCNO>NCT01802151</DOCNO>
	<brief_summary>The purpose study evaluate effect three dose probiotic B. subtilis ( Bacillus subtilis R0179 ) deliver capsule gastrointestinal general wellness healthy young adult , survival gastrointestinal tract impact intestinal microbe .</brief_summary>
	<brief_title>Evaluation Bacillus Subtilis R0179 Healthy Young Adults</brief_title>
	<detailed_description>A 6 week randomize , double blind placebo control trial healthy young adult age 18 50 . Participants administer oral dose B. subtilis placebo ( 1 capsule/day ) period 4 week . Viable count measure stool sample assess transit survival , daily questionnaire ( DQ ) administer assess general wellness , gastrointestinal ( GI ) symptom evaluate three time Gastrointestinal Symptom Response Scale ( GSRS ) questionnaire .</detailed_description>
	<criteria>Participants Are 1850 year age Are willing able complete Informed Consent Form English Are willing complete GPAQ ( Global Physical Activity Questionnaire ) baseline last week study well complete GSRS ( Gastrointestinal Symptom Response Survey ) questionnaire baseline , treatment post treatment Are currently `` moderately active '' determine GPAQ ( Global Physical Activity Questionnaire ) Are willing height weight measure provide demographic information ( age , race , sex ) Are willing consume B. subtilis R0179 ( approximate dos 1 , 10 , 0.1 billion CFU per day ) placebo 28 day period capsule ( 1 per day ) Are willing complete daily questionnaire regard general gastrointestinal wellness duration study Are willing provide 1 stool baseline , 1 stool week 4 treatment 1 stool 7 day washout Are willing provide social security number receive study payment . Note : subject still participate unwilling provide social security number , financial reimbursement provide Are willing internet access duration study Potential Participants exclude Do meet inclusion criterion Are currently take medication constipation diarrhea Have take antibiotic within past four week prior randomization Are currently take probiotic supplement want discontinue minimum two week prior study Known currently treat disease illnesses gastrointestinal disease ( gastric ulcer , Crohn 's , ulcerative colitis , etc . ) , chronic disease ( diabetes , kidney disease , etc . ) immunecompromising disease condition ( HIV , AIDS , autoimmune , hepatitis , cancer , transplant patient etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>probiotic</keyword>
	<keyword>microbiota</keyword>
	<keyword>survival</keyword>
	<keyword>gastrointestinal</keyword>
	<keyword>wellness</keyword>
</DOC>